Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RUBY | DRMA | SLXN | ||
| Company | Rubius Therapeutics Inc | Dermata Therapeutics Inc | Silexion Therapeutics Corp | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0555 | 1.7900 | 1.7300 | ||
| High | 0.0570 | 1.7900 | 1.8000 | ||
| Low | 0.0550 | 1.6000 | 1.7300 | ||
| Latest | 0.0570 | 1.6310 | 1.7600 | ||
| Change | +0.0015 | -0.1990 | +0.1500 | ||
| % Change | +2.70% | -10.87% | +9.32% | ||
| Volume | 755,800 | 165,269 | 45,553 | ||
| 20-Day Average Volume | 190,760 | 1,880,868 | 45,579 | ||
| Previous Close | 0.0555 | 1.8300 | 1.6100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0272 | 2.1890 | 1.9913 | ||
| 20-Day Raw Stochastic | 100.00% | 1.01% | 22.83% | ||
| 20-Day Relative Strength | 84.64 | 41.01 | 39.48 | ||
| Weighted Alpha | -42.49 | -88.25 | -85.97 | ||
| Today's Opinion | 88% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 88% Buy | 96% Sell | 100% Sell | ||
| Last Month's Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.00% since 12/21/23 | -19.26% since 02/02/26 | -2.67% since 02/02/26 | ||
| Low | 0.0200 on 12/22/23 | 1.6000 on 02/09/26 | 1.5100 on 02/05/26 | ||
| High | 0.0570 on 12/29/23 | 2.0900 on 02/04/26 | 1.8800 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | +200.00% since 11/29/23 | -21.59% since 01/09/26 | -17.36% since 01/09/26 | ||
| Low | 0.0181 on 12/01/23 | 1.6000 on 02/09/26 | 1.5100 on 02/05/26 | ||
| High | 0.0570 on 12/29/23 | 4.6600 on 01/26/26 | 2.5699 on 01/15/26 | ||
| 3-Month | |||||
| %Chg | +251.85% since 09/29/23 | -46.35% since 11/07/25 | -37.20% since 11/07/25 | ||
| Low | 0.0162 on 10/09/23 | 1.5800 on 12/29/25 | 1.5100 on 02/05/26 | ||
| High | 0.0570 on 12/29/23 | 4.6600 on 01/26/26 | 3.2380 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | +216.67% since 06/29/23 | -74.74% since 08/08/25 | -78.71% since 08/08/25 | ||
| Low | 0.0032 on 09/25/23 | 1.5800 on 12/29/25 | 1.5100 on 02/05/26 | ||
| High | 0.1150 on 09/11/23 | 6.5750 on 08/13/25 | 8.2900 on 08/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,158 | 5,189 | 5,034 | ||
| Shares Outstanding, K | 90,483 | 2,835 | 3,127 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -179,670,000 | -12,290,000 | -16,440,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -20,140,000 | -1,690,000 | -3,260,000 | ||
| 60-Month Beta | 2.20 | 0.55 | -0.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.65 on 11/14/25 | -2.88 on 11/12/25 | ||
| Latest Earnings Date | 01/01/70 | 03/16/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||